Accueil » Communiqués de presse » Valbiotis announces the first visit of the first patientin the TOTUM•63 mode of action clinical study conducted by the INAF1, in partnership with Nestlé Health Science
Les communiqués de presse
28Apr2022
Valbiotis announces the first visit of the first patientin the TOTUM•63 mode of action clinical study conducted by the INAF1, in partnership with Nestlé Health Science
We use cookies to guarantee the best experience on our site, to make statistics, to offer you third party services such as video like Youtube, social networks sharing. By clicking on validate and closing this banner, you accept the deposit of cookies.AcceptRefuseMore information
You can revoke your consent at any time by using the "Revoke Consent" button.Revoke consent
